Dr. Saraf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4852 Penn Ave
Penn, PA 15675
Education & Training
- Baylor College of MedicineClass of 2010
Certifications & Licensure
- PA State Medical License 2020 - 2026
- GA State Medical License 2019 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Efficacy of Sodium Glucose Transporter Inhibitor (SGLT2I) in Adult Patients with Congenital Heart Disease Start of enrollment: 2024 Sep 17
Roles: Sponsor-Investigator, Contact, Principal Investigator
Publications & Presentations
PubMed
- Characteristics and Survival Outcomes of Hepatocellular Carcinoma After the Fontan Operation.Benjamin E Rosenthal, Maarouf A Hoteit, Gentian Lluri, Christiane Haeffele, Tami Daugherty
JACC. Advances. 2025-03-12 - Lower Child Opportunity Index is Associated with Lower Exercise Capacity Post-Fontan Palliation.Brock A Karolcik, Li Wang, Maya I Ragavan, Arvind K Hoskoppal, Anita P Saraf
Pediatric Cardiology. 2024-12-30 - Impact of guideline directed medical therapy on myocardial function in adults with congenital heart disease.Carley Bright, Afshan Rizvi, Francis Ezekwueme, Mary Schiff, Jennifer Kliner
International Journal of Cardiology. 2024-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: